Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 3, 2024Chemistry & BiodiversityOpen Access

Exploring The Antimicrobial Potential of Novel 1,2,4‒Triazole Conjugates with Pyrazole: Synthesis, Biological Activity and In Silico Docking

View Full Paper
Ask AI
Bookmark
Share

Authors

GKGanesh Babu N. V. N. KolukulaSSSibbala SubramanyamTATejeswara Rao Allaka

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kolukula et al. (2024) studied this question.

synapsesocial.com/papers/68e597d2b6db6435875321a2https://doi.org/10.1002/cbdv.202401810
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Synthesis, Characterization, Computational Studies and In Vitro Biological Effects of Novel Pyrazoles, Pyridazines, Thiazoles Containing a Quinazoline Scaffold2025
  2. 2Pyrazine-Linked 1,2,3-Triazole Derivatives: Synthesis, Characterization, In Vitro Antimicrobial Evaluation, and Docking Study2026
  3. 3Design, Synthesis, Antimicrobial Evaluation and Molecular Docking of New Pyrrolidinone–1,2,4‐ Mercapto Triazole Hybrids Fused as Multifunctional Therapeutic Agents2026
  4. 4Synthesis, Molecular Docking Studies and In Vitro Antimicrobial Evaluation of Peptide Linked Trifluoromethyl Triazolo‐Pyrazine Derivatives2025
  5. 5Synthesis, Biological Activity, and Docking Studies of the Fused Pyrazoline and Thiazole Hybrids2026